{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:16:45Z","timestamp":1779909405248,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T00:00:00Z","timestamp":1531785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s40263-018-0544-2","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T07:48:20Z","timestamp":1531813700000},"page":"771-781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Use of Emergency Medication in Adult Patients with Epilepsy: A Multicentre Cohort Study from Germany"],"prefix":"10.1007","volume":"32","author":[{"given":"Jeannette","family":"Kadel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke M.","family":"Hermsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilka","family":"Immisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Martin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Knake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Menzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp S.","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Rosenow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6288-9915","authenticated-orcid":false,"given":"Adam","family":"Strzelczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,17]]},"reference":[{"issue":"12","key":"544_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM199809173391202","volume":"339","author":"DM Treiman","year":"1998","unstructured":"Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12):792\u20138.","journal-title":"N Engl J Med."},{"issue":"Suppl 1","key":"544_CR2","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.eplepsyres.2005.07.020","volume":"68","author":"DM Treiman","year":"2006","unstructured":"Treiman DM, Walker MC. Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus. Epilepsy Res. 2006;68(Suppl 1):S77\u201382.","journal-title":"Epilepsy Res"},{"issue":"9","key":"544_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa002141","volume":"345","author":"BK Alldredge","year":"2001","unstructured":"Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9):631\u20137.","journal-title":"N Engl J Med."},{"issue":"3","key":"544_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s40263-018-0509-5","volume":"32","author":"I Beuchat","year":"2018","unstructured":"Beuchat I, Novy J, Rossetti AO. Newer antiepileptic drugs for status epilepticus in adults: what\u2019s the evidence? CNS Drugs. 2018;32(3):259\u201367.","journal-title":"CNS Drugs"},{"issue":"4","key":"544_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00431-011-1403-z","volume":"170","author":"L Lagae","year":"2011","unstructured":"Lagae L. Clinical practice: the treatment of acute convulsive seizures in children. Eur J Pediatr. 2011;170(4):413\u20138.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"544_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0887-8994(91)90099-7","volume":"7","author":"RL Kriel","year":"1991","unstructured":"Kriel RL, Cloyd JC, Hadsall RS, Carlson AM, Floren KL, Jones-Saete CM. Home use of rectal diazepam for cluster and prolonged seizures: efficacy, adverse reactions, quality of life, and cost analysis. Pediatr Neurol. 1991;7(1):13\u20137.","journal-title":"Pediatr Neurol."},{"issue":"4","key":"544_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.seizure.2007.11.002","volume":"17","author":"A Timmerman","year":"2008","unstructured":"Timmerman A, Jennekens-Schinkel A, Oostrom KJ, van Nieuwenhuizen O. Stesolid emergency treatment: cave social fear! Seizure. 2008;17(4):333\u20138.","journal-title":"Seizure."},{"issue":"6","key":"544_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1525-5050(02)00559-0","volume":"3","author":"IW Tatum","year":"2002","unstructured":"Tatum IW. Adult patient perceptions of emergency rectal medications for refractory seizures. Epilepsy Behav. 2002;3(6):535\u20138.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"544_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1528-1167.2009.02333.x","volume":"51","author":"GJ Haan de","year":"2010","unstructured":"de Haan GJ, van der Geest P, Doelman G, Bertram E, Edelbroek P. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia. 2010;51(3):478\u201382.","journal-title":"Epilepsia."},{"issue":"8","key":"544_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/archpediatrics.2010.130","volume":"164","author":"M Holsti","year":"2010","unstructured":"Holsti M, Dudley N, Schunk J, Adelgais K, Greenberg R, Olsen C, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. 2010;164(8):747\u201353.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"9","key":"544_CR11","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/epi.13088","volume":"56","author":"L Kay","year":"2015","unstructured":"Kay L, Reif PS, Belke M, Bauer S, Frund D, Knake S, et al. Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures. Epilepsia. 2015;56(9):1408\u201314.","journal-title":"Epilepsia."},{"issue":"7253","key":"544_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bmj.321.7253.83","volume":"321","author":"E Lahat","year":"2000","unstructured":"Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch M. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ. 2000;321(7253):83\u20136.","journal-title":"BMJ"},{"issue":"9","key":"544_CR13","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/epi.12685","volume":"55","author":"J Rogin","year":"2014","unstructured":"Rogin J, Wheless J, Abou-Khalil B, Wolter KD, Pixton GC, Sherman NA, et al. Safety and effectiveness of long-term treatment with diazepam auto-injector administered by caregivers in an outpatient setting for the treatment of acute repetitive seizures. Epilepsia. 2014;55(9):1444\u201351.","journal-title":"Epilepsia."},{"issue":"7","key":"544_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","volume":"366","author":"R Silbergleit","year":"2012","unstructured":"Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591\u2013600.","journal-title":"N Engl J Med."},{"issue":"1","key":"544_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40263-016-0398-4","volume":"31","author":"M Mula","year":"2017","unstructured":"Mula M. New non-intravenous routes for benzodiazepines in epilepsy: a clinician perspective. CNS Drugs. 2017;31(1):11\u20137.","journal-title":"CNS Drugs"},{"issue":"5","key":"544_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ejpn.2010.05.009","volume":"14","author":"MR Ashrafi","year":"2010","unstructured":"Ashrafi MR, Khosroshahi N, Karimi P, Malamiri RA, Bavarian B, Zarch AV, et al. Efficacy and usability of buccal midazolam in controlling acute prolonged convulsive seizures in children. Eur J Paediatr Neurol. 2010;14(5):434\u20138.","journal-title":"Eur J Paediatr Neurol."},{"issue":"9481","key":"544_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","volume":"366","author":"J McIntyre","year":"2005","unstructured":"McIntyre J, Robertson S, Norris E, Appleton R, Whitehouse WP, Phillips B, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366(9481):205\u201310.","journal-title":"Lancet"},{"issue":"9153","key":"544_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0140-6736(98)06425-3","volume":"353","author":"RC Scott","year":"1999","unstructured":"Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999;353(9153):623\u20136.","journal-title":"Lancet"},{"issue":"9","key":"544_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s40263-015-0271-x","volume":"29","author":"F Brigo","year":"2015","unstructured":"Brigo F, Nardone R, Tezzon F, Trinka E. A common reference-based indirect comparison meta-analysis of buccal versus intranasal midazolam for early status epilepticus. CNS Drugs. 2015;29(9):741\u201357.","journal-title":"CNS Drugs"},{"issue":"6","key":"544_CR20","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1046\/j.1528-1157.2001.01101.x","volume":"42","author":"S Knake","year":"2001","unstructured":"Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001;42(6):714\u20138.","journal-title":"Epilepsia."},{"issue":"4","key":"544_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.yebeh.2012.01.021","volume":"23","author":"A Strzelczyk","year":"2012","unstructured":"Strzelczyk A, Nickolay T, Bauer S, Haag A, Knake S, Oertel WH, et al. Evaluation of health-care utilization among adult patients with epilepsy in Germany. Epilepsy Behav. 2012;23(4):451\u20137.","journal-title":"Epilepsy Behav"},{"issue":"12","key":"544_CR22","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1111\/epi.13584","volume":"57","author":"LM Kortland","year":"2016","unstructured":"Kortland LM, Alfter A, Bahr O, Carl B, Dodel R, Freiman TM, et al. Costs and cost-driving factors for acute treatment of adults with status epilepticus: a multicenter cohort study from Germany. Epilepsia. 2016;57(12):2056\u201366.","journal-title":"Epilepsia."},{"issue":"7624","key":"544_CR23","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E Elm von","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806\u20138.","journal-title":"BMJ."},{"issue":"4","key":"544_CR24","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/epi.13670","volume":"58","author":"RS Fisher","year":"2017","unstructured":"Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522\u201330.","journal-title":"Epilepsia."},{"issue":"4","key":"544_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512\u201321.","journal-title":"Epilepsia."},{"issue":"2","key":"544_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.0013-9580.2004.14103.x","volume":"45","author":"E Beghi","year":"2004","unstructured":"Beghi E, Garattini L, Ricci E, Cornago D, Parazzini F. Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS). Epilepsia. 2004;45(2):171\u20138.","journal-title":"Epilepsia."},{"issue":"3","key":"544_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0920-1211(02)00013-X","volume":"48","author":"A Tetto","year":"2002","unstructured":"Tetto A, Manzoni P, Millul A, Beghi E, Garattini L, Tartara A, et al. The costs of epilepsy in Italy: a prospective cost-of-illness study in referral patients with disease of different severity. Epilepsy Res. 2002;48(3):207\u201316.","journal-title":"Epilepsy Res"},{"key":"544_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.seizure.2015.01.010","volume":"26","author":"AH Noda","year":"2015","unstructured":"Noda AH, Hermsen A, Berkenfeld R, Dennig D, Endrass G, Kaltofen J, et al. Evaluation of costs of epilepsy using an electronic practice management software in Germany. Seizure. 2015;26:49\u201355.","journal-title":"Seizure."},{"issue":"83","key":"544_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.yebeh.2018.03.025","volume":"9","author":"LM Willems","year":"2018","unstructured":"Willems LM, Richter S, Watermann N, Bauer S, Klein KM, Reese JP, et al. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013\u2014a ten-year overview. Epilepsy Behav. 2018;9(83):28\u201335.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"544_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1006\/ebeh.2001.0170","volume":"2","author":"TW May","year":"2001","unstructured":"May TW, Pfafflin M, Cramer JA. Psychometric properties of the German translation of the QOLIE-31. Epilepsy Behav. 2001;2(2):106\u201314.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"544_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.yebeh.2012.10.004","volume":"25","author":"B Metternich","year":"2012","unstructured":"Metternich B, Wagner K, Buschmann F, Anger R, Schulze-Bonhage A. Validation of a German version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). Epilepsy Behav. 2012;25(4):485\u20138.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"544_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1528-1167.2006.00956.x","volume":"48","author":"RJ Panelli","year":"2007","unstructured":"Panelli RJ, Kilpatrick C, Moore SM, Matkovic Z, D\u2019Souza WJ, O\u2019Brien TJ. The Liverpool adverse events profile: relation to AED use and mood. Epilepsia. 2007;48(3):456\u201363.","journal-title":"Epilepsia."},{"issue":"4","key":"544_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1212\/WNL.0000000000004147","volume":"89","author":"S Semmlack","year":"2017","unstructured":"Semmlack S, Yeginsoy D, Spiegel R, Tisljar K, Ruegg S, Marsch S, et al. Emergency response to out-of-hospital status epilepticus: a 10-year observational cohort study. Neurology. 2017;89(4):376\u201384.","journal-title":"Neurology."},{"issue":"2","key":"544_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/jps.2600710227","volume":"71","author":"DJ Greenblatt","year":"1982","unstructured":"Greenblatt DJ, Divoll M, Harmatz JS, Shader RI. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam. J Pharm Sci. 1982;71(2):248\u201352.","journal-title":"J Pharm Sci"},{"issue":"3","key":"544_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/cpt1976203329","volume":"20","author":"DJ Greenblatt","year":"1976","unstructured":"Greenblatt DJ, Schillings RT, Kyriakopoulos AA, Shader RI, Sisenwine SF, Knowles JA, et al. Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam. Clin Pharmacol Ther. 1976;20(3):329\u201341.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"544_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","volume":"118","author":"J Riss","year":"2008","unstructured":"Riss J, Cloyd J, Gates J, Collins S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008;118(2):69\u201386.","journal-title":"Acta Neurol Scand"},{"key":"544_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yebeh.2015.03.023","volume":"49","author":"J Dobesberger","year":"2015","unstructured":"Dobesberger J, Ristic AJ, Walser G, Kuchukhidze G, Unterberger I, Hofler J, et al. Duration of focal complex, secondarily generalized tonic-clonic, and primarily generalized tonic-clonic seizures\u2014a video-EEG analysis. Epilepsy Behav. 2015;49:111\u20137.","journal-title":"Epilepsy Behav"},{"issue":"12","key":"544_CR38","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1111\/j.1528-1157.1999.tb01607.x","volume":"40","author":"SR Haut","year":"1999","unstructured":"Haut SR, Shinnar S, Moshe SL, O\u2019Dell C, Legatt AD. The association between seizure clustering and convulsive status epilepticus in patients with intractable complex partial seizures. Epilepsia. 1999;40(12):1832\u20134.","journal-title":"Epilepsia."},{"issue":"4","key":"544_CR39","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yebeh.2017.03.010","volume":"Pt A","author":"R Shankar","year":"2017","unstructured":"Shankar R, Jory C, McLean B, Tittensor P, Walker M. Epilepsy awareness and emergency rescue training: ignorance is bliss. Epilepsy Behav. 2017;Pt A(4):212\u20136.","journal-title":"Epilepsy Behav."},{"issue":"Suppl 6","key":"544_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/epi.12284","volume":"54","author":"R Silbergleit","year":"2013","unstructured":"Silbergleit R, Lowenstein D, Durkalski V, Conwit R, Investigators N. Lessons from the RAMPART study\u2013and which is the best route of administration of benzodiazepines in status epilepticus. Epilepsia. 2013;54(Suppl 6):74\u20137.","journal-title":"Epilepsia."},{"issue":"1","key":"544_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40263-016-0389-5","volume":"31","author":"R Sutter","year":"2017","unstructured":"Sutter R, De Marchis GM, Semmlack S, Fuhr P, Ruegg S, Marsch S, et al. Anesthetics and outcome in status epilepticus: a matched two-center cohort study. CNS Drugs. 2017;31(1):65\u201374.","journal-title":"CNS Drugs"},{"key":"544_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13561-014-0006-6","volume":"4","author":"DC Lee","year":"2014","unstructured":"Lee DC, Gladwell D, Hatswell AJ, Porter J, Brereton N, Tate E, et al. A comparison of the cost-effectiveness of treatment of prolonged acute convulsive epileptic seizures in children across Europe. Health Econ Rev. 2014;4:6.","journal-title":"Health Econ Rev"},{"key":"544_CR43","volume-title":"CG137 The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care","author":"NICE","year":"2012","unstructured":"NICE. CG137 The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. London:NICE; 2012."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-018-0544-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0544-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0544-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T11:35:19Z","timestamp":1576755319000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-018-0544-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,17]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1007\/s40263-018-0544-2","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,17]]},"assertion":[{"value":"17 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was supported by an unrestricted grant by Desitin Arzneimittel.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"J. Kadel, S. Bauer, A. M. Hermsen, I. Immisch, L. Kay, P. S. Reif report no conflicts of interest. K. M. Klein reports personal fees from UCB, Eisai, GW Pharmaceuticals and Novartis, outside the submitted work. S. Knake reports personal fees from Desitin, Eisai, UCB, as well as support for scientific meetings from AD-tech, Desitin, Eisai, GW Pharmaceuticals, LivaNova, Nihon Kohden and Novartis outside the submitted work. K. Menzler reports honoraria as advisory board member from Eisai and UCB, outside the submitted work. F. Rosenow reports personal fees from Eisai, grants and personal fees from UCB, grants and personal fees from Desitin Pharma, personal fees and other from Novartis, personal fees from Medronic, personal fees from Cerbomed, personal fees from ViroPharma and Shire, grants from European Union, grants from Deutsche Forschungsgemeinschaft, outside the submitted work. A. Strzelczyk reports personal fees and grants from Desitin Arzneimittel, Eisai, LivaNova, Sage Therapeutics, UCB Pharma and Zogenix, outside the submitted work. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}